Tech Briefing: Amazon holds engineering meeting following AI-related outages Strategic angle: The tech giant addresses recent disruptions in its AI services. Editorial Staff Mar 10
Tech Briefing: Show HN: I Was Here – Draw on street view, others can find your drawings Strategic angle: A new site allows users to draw on street-level panoramas, making art interactive and visible to others in real time. Editorial Staff Mar 10
Politics Briefing: Ex-Meta AI chief Yann LeCun's AMI raises $1.03 billion for alternative AI approach Strategic angle: Yann LeCun's new venture secures significant funding to explore innovative AI methodologies. Editorial Staff Mar 10
Money Briefing: Yann LeCun’s AI start-up raises more than $1bn in Europe’s largest seed round Strategic angle: Meta’s former chief AI scientist launches AMI Labs with backing from Nvidia, Temasek and Jeff Bezos Editorial Staff Mar 10
Money Briefing: Can the G7 release enough oil to calm the market? Strategic angle: Analysts are sceptical that releasing strategic reserves would solve the problems in the Gulf. Editorial Staff Mar 10
Money Briefing: Israel expects Lebanon offensive to outlast Iran conflict Strategic angle: IDF preparing extended campaign against militant group Hizbollah, according to people familiar with discussions Editorial Staff Mar 10
Money Briefing: The handymen and drivers keeping Tehran running Strategic angle: Even under bombardment, workers across Iran’s capital are delivering food and fixing potholes Editorial Staff Mar 10
Life Briefing: Bombing of Iran’s oil infrastructure to have major environmental fallout, experts warn Strategic angle: Experts caution that the ongoing conflict and bombings will lead to significant long-term environmental damage. Editorial Staff Mar 10
Tech Briefing: Windows: Microsoft broke the only thing that mattered Strategic angle: A critical look at Microsoft's recent changes to Windows that have sparked widespread concern among developers. Editorial Staff Mar 10
Life Briefing: Over-the-Counter Oral Contraceptive Pills Approved Strategic angle: FDA approves Opill, marking a significant change in access to oral contraceptives in the U.S. Editorial Staff Mar 10